Related Experiment Video

Updated: Mar 6, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K

Genetic Variations of Tyrosine Hydroxylase in the Pathogenesis of Hypertension

Yu Ho Lee1, Yang Gyun Kim1, Ju-Young Moon1

  • 1Division of Nephrology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.

Electrolyte & Blood Pressure : E & BP
|March 10, 2017
PubMed

Insights

Genetic variations in tyrosine hydroxylase (TH), an enzyme crucial for catecholamine synthesis, may influence sympathetic nervous system activity and contribute to primary hypertension development. Further research is needed to understand this link.

Area of Science:

  • Biochemistry
  • Genetics
  • Cardiovascular Physiology

Background:

  • Primary hypertension is linked to overactive sympathetic nervous system activity.
  • This overactivity involves excessive catecholamine synthesis and secretion.
  • Tyrosine hydroxylase (TH) is a key enzyme regulating catecholamine production.

Purpose of the Study:

  • To explore the role of tyrosine hydroxylase (TH) in regulating sympathetic nervous system activity.
  • To review existing studies on the association between genetic variations in the TH gene and hypertension.
  • To understand the potential contribution of TH genetic variations to hypertension pathogenesis.

Main Methods:

  • Literature review of studies investigating tyrosine hydroxylase (TH).
  • Analysis of research examining genetic variations in the TH gene.
  • Correlation analysis between TH gene polymorphisms and hypertension incidence/severity.

Main Results:

  • Tyrosine hydroxylase (TH) plays a critical role in catecholamine synthesis, impacting sympathetic tone.
  • Several genetic variations within the TH gene have been identified.
  • Some studies suggest a correlation between specific TH polymorphisms and altered hypertension risk or severity.

Conclusions:

  • Tyrosine hydroxylase (TH) is a significant regulator of sympathetic activity.
  • Genetic variations in TH may represent a contributing factor to the development of primary hypertension.
  • Further investigation into TH genetics is warranted for a comprehensive understanding of hypertension pathophysiology.

Keywords:
HypertensionSingle nucleotide polymorphismTyrosine hydroxylase

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.3K
Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice09:35

Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice

Published on: January 20, 2015

9.3K

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
76
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.8K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
65